Clinical Trials in Çankaya, Ankara

17 recruiting

Showing 117 of 17 trials

Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC270 enrolled45 locationsNCT06818643
Recruiting

Evaluation of Satisfaction and Experiences in Patients Undergoing Awake Intubation.

Awake Endotracheal Intubation
Hacettepe University100 enrolled1 locationNCT07574905
Recruiting
Phase 3

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

Niemann-Pick Type C Disease
Azafaros A.G.72 enrolled34 locationsNCT07082725
Recruiting
Phase 3

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Gangliosidoses, GM2Gangliosidosis, GM1
Azafaros A.G.75 enrolled36 locationsNCT07082543
Recruiting
Phase 3

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

GM1 GangliosidosisGM2 GangliosidosisNiemann-Pick Type C Disease
Azafaros A.G.147 enrolled37 locationsNCT07054515
Recruiting
Phase 3

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Endometrial Cancer
Karyopharm Therapeutics Inc276 enrolled217 locationsNCT05611931
Recruiting
Phase 3

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Metastatic Breast Cancer
LeonaBio500 enrolled224 locationsNCT05696626
Recruiting
Phase 3

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer
AbbVie698 enrolled316 locationsNCT04928846
Recruiting
Phase 3

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Advanced Melanoma
Immunocore Ltd680 enrolled211 locationsNCT06112314
Recruiting
Not Applicable

Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients

Parkinson Disease
Ankara City Hospital Bilkent42 enrolled2 locationsNCT07390825
Recruiting
Phase 3

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Peripheral T Cell Lymphoma
Acrotech Biopharma Inc.504 enrolled69 locationsNCT06072131
Recruiting

Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients

Juvenile Idiopathic Arthritis (JIA)Childhood Rheumatic Diseases
Hacettepe University50 enrolled1 locationNCT07185750
Recruiting

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

swallowingSclerodermaSystemic Sclerosis (SSc)+2 more
Hacettepe University50 enrolled1 locationNCT07182981
Recruiting

Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire

Systemic sclerosis SclerodermaSystemic Sclerosis (SSc)Scleroderma (Limited and Diffuse)+1 more
Hacettepe University50 enrolled1 locationNCT07182968
Recruiting

Patients Diagnosed With Scleroderma: Physical Performance and Functionality

SclerodermaSystemic Sclerosis (SSc)Functionality+2 more
Hacettepe University50 enrolled1 locationNCT07183072
Recruiting
Phase 3

Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant

Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology Disorders+1 more
Vanda Pharmaceuticals60 enrolled1 locationNCT06701396
Recruiting

Relationship Between Albumin/Creatine Ratio, B12, Folate, and Frailty Index

Frailty
Ankara Etlik City Hospital40 enrolled2 locationsNCT06393647